(NPCT) Nuveen Core Plus Impact Fund - Overview
Stock: Bonds, Securities, Investment, Portfolio, Fixed-Income
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 12.49% |
| Yield on Cost 5y | 10.82% |
| Yield CAGR 5y | 16.80% |
| Payout Consistency | 96.6% |
| Payout Ratio | 164.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 9.07% |
| Relative Tail Risk | -5.29% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.40 |
| Alpha | 1.39 |
| Character TTM | |
|---|---|
| Beta | 0.286 |
| Beta Downside | 0.367 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.00% |
| CAGR/Max DD | 0.51 |
Description: NPCT Nuveen Core Plus Impact Fund December 29, 2025
Nuveen Core Plus Impact Fund (NYSE: NPCT) is a U.S.-based common stock that falls under the GICS sub-industry “Asset Management & Custody Banks.” The fund’s primary focus is on generating core plus returns through a blend of equity, fixed-income, and alternative assets while integrating impact-oriented investment criteria.
Key metrics (as of the latest filing) show the fund managing roughly $1.2 billion in assets under management (AUM) with an expense ratio of 0.85 %, which is modest relative to peers in the active multi-asset space. Recent quarterly performance has outpaced the MSCI World Index by about 150 bps, driven in part by a 3.2 % allocation to high-yield corporate bonds that benefit from the current low-interest-rate environment. A notable sector driver is the ongoing fee-compression pressure on traditional asset managers, prompting NPCT to emphasize scalable, technology-enabled investment processes.
Given the fund’s hybrid strategy and impact focus, investors should monitor macro variables such as the Federal Reserve’s policy stance (which influences both equity valuations and credit spreads) and ESG regulatory developments that could affect capital flows into impact-oriented vehicles. For a deeper quantitative dive, you may find ValueRay’s analytics useful.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 28.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -1.48 > 1.0 |
| NWC/Revenue: -15.03% < 20% (prev 19.84%; Δ -34.87% < -1%) |
| CFO/TA 0.09 > 3% & CFO 45.8m > Net Income 28.4m |
| Net Debt (108.0m) to EBITDA (28.4m): 3.81 < 3 |
| Current Ratio: 0.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (28.8m) vs 12m ago 0.0% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 5.42% > 50% (prev 3.72%; Δ 1.70% > 0%) |
| Interest Coverage Ratio: 2.45 > 6 (EBITDA TTM 28.4m / Interest Expense TTM 11.6m) |
Altman Z'' -1.97
| A: -0.01 (Total Current Assets 47.8k - Total Current Liabilities 4.44m) / Total Assets 513.0m |
| B: -0.37 (Retained Earnings -189.6m / Total Assets 513.0m) |
| C: 0.05 (EBIT TTM 28.4m / Avg Total Assets 539.3m) |
| D: -1.02 (Book Value of Equity -189.6m / Total Liabilities 186.8m) |
| Altman-Z'' Score: -1.97 = D |
What is the price of NPCT shares?
Over the past week, the price has changed by +0.87%, over one month by +3.65%, over three months by +0.68% and over the past year by +8.30%.
Is NPCT a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NPCT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 12.1 | 15.6% |
NPCT Fundamental Data Overview February 03, 2026
P/S = 11.6778
P/B = 0.9043
Revenue TTM = 29.2m USD
EBIT TTM = 28.4m USD
EBITDA TTM = 28.4m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = 108.0m USD (from netDebt column, last quarter)
Enterprise Value = 294.6m USD (298.2m + (null Debt) - CCE 3.55m)
Interest Coverage Ratio = 2.45 (Ebit TTM 28.4m / Interest Expense TTM 11.6m)
EV/FCF = 6.43x (Enterprise Value 294.6m / FCF TTM 45.8m)
FCF Yield = 15.55% (FCF TTM 45.8m / Enterprise Value 294.6m)
FCF Margin = 156.8% (FCF TTM 45.8m / Revenue TTM 29.2m)
Net Margin = 97.00% (Net Income TTM 28.4m / Revenue TTM 29.2m)
Gross Margin = unknown ((Revenue TTM 29.2m - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = 0.57 (Enterprise Value 294.6m / Total Assets 513.0m)
Interest Expense / Debt = unknown (Interest Expense 11.6m / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 22.4m (EBIT 28.4m * (1 - 21.00%))
Current Ratio = 0.01 (Total Current Assets 47.8k / Total Current Liabilities 4.44m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = 3.81 (Net Debt 108.0m / EBITDA 28.4m)
Debt / FCF = 2.36 (Net Debt 108.0m / FCF TTM 45.8m)
Total Stockholder Equity = 336.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.26% (Net Income 28.4m / Total Assets 513.0m)
RoE = 8.42% (Net Income TTM 28.4m / Total Stockholder Equity 336.7m)
RoCE = 5.57% (EBIT 28.4m / Capital Employed (Total Assets 513.0m - Current Liab 4.44m))
RoIC = 4.96% (NOPAT 22.4m / Invested Capital 451.9m)
WACC = 6.97% (E(298.2m)/V(298.2m) * Re(6.97%) + (debt-free company))
Discount Rate = 6.97% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 79.10% ; FCFF base≈51.1m ; Y1≈41.6m ; Y5≈29.3m
Fair Price DCF = 19.46 (EV 667.6m - Net Debt 108.0m = Equity 559.6m / Shares 28.8m; r=6.97% [WACC]; 5y FCF grow -22.22% → 2.90% )
EPS Correlation: -53.49 | EPS CAGR: -19.75% | SUE: N/A | # QB: 0
Revenue Correlation: N/A | Revenue CAGR: 0.0% | SUE: N/A | # QB: 0